ABLYSINOL Drug Patent Profile
When do Ablysinol patents expire, and when can generic versions of Ablysinol launch?
Ablysinol is a drug marketed by Bpi Labs and is included in one NDA.
The generic ingredient in ABLYSINOL is dehydrated alcohol. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the dehydrated alcohol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ablysinol
A generic version of ABLYSINOL was approved as dehydrated alcohol by ACCORD HLTHCARE on June 23rd, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ABLYSINOL?
- What are the global sales for ABLYSINOL?
- What is Average Wholesale Price for ABLYSINOL?
Summary for ABLYSINOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 370 |
| DailyMed Link: | ABLYSINOL at DailyMed |
US Patents and Regulatory Information for ABLYSINOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | ABLYSINOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 207987-001 | Jun 21, 2018 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bpi Labs | ABLYSINOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
